Awards

2021 Young Investigators Award Recipients

Congratulations to the 2021 Young Investigators Award recipients:

Shintaro Akiyama, MD, PhD
University of Chicago
THE CLINICAL FEATURES AND PROGNOSTIC VALUE OF INFLAMMATORY POLYPS IN THE J POUCH OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED BY PROCTOCOLECTOMY WITH ILEAL POUCH-ANAL ANASTOMOSIS

Sarah Choi, MD, MS
Cleveland Clinic
IS ILEOANAL POUCH EXCISION A DESTINATION THERAPY FOR INFLAMMATORY BOWEL DISEASE? DATA FROM A QUATERNARY POUCH REFERRAL CENTER

Federica Crispino, MD
Azienda Ospedaliera Universitaria Policlinico
BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN’S PATIENTS TREATED WITH BIOLOGICS: A NEW PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES

Melinda Engevik, PhD
Baylor College of Medicine, Medical University of South Carolina
EXPLORING CO-INFECTIONS IN THE GASTROINTESTINAL TRACT: DISSECTING THE INTERACTION BETWEEN FUSOBACTERIUM NUCLEATUM AND CLOSTRIDIODES DIFFICILE

Safina Gadeock, PhD
Children’s Hospital Los Angeles
MESENCHYMAL TNFR1 EXPRESSION PRESERVES THE COLONIC EPITHELIAL STEM CELL NICHE

Wei-Ting Kuo, PhD
Brigham and Women’s Hospital
THE TIGHT JUNCTION PROTEIN ZO-1 REGULATES MITOTIC SPINDLE ORIENTATION TO ENABLE EFFICIENT MUCOSAL REPAIR

Jiannan Li, MD, PhD
Cleveland Clinic
CADHERIN-11, AN ESSENTIAL REGULATOR OF CELL-CELL ADHESION UPREGULATED IN IBD PATIENTS, PLAYS ESSENTIAL ROLES IN PROMOTING FIBROBLAST ACTIVATION AND DEVELOPMENT OF INTESTINAL INFLAMMATION AND FIBROSIS

Yoshihiro Morimoto, PhD
Dana Farber Cancer Institute, Harvard Medical School
MUC1-C IS A DRUGGABLE TARGET FOR TREATMENT OF COLITIS AND PROGRESSION OF COLITIS-ASSOCIATED COLORECTAL CANCER

Zach Picciarelli, BS
University of Pittsburgh School of Medicine
EXPLORING THE REPRODUCTIVE HEALTH DECISION EXPERIENCES AND PREFERENCES OF WOMEN WITH INFLAMMATORY BOWEL DISEASES

Wenly Ruan, MD
Baylor College of Medicine, Texas Children’s Hospital
SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS

Sana Syed, MD, MS
University of Virginia School of Medicine
MACHINE LEARNING FOR CROHN’S DISEASE PHENOTYPE MODELING USING BIOPSY IMAGES

Divek V.T. Nair, PhD
The Pennsylvania State University
DIETARY FIBER GUAR GUM EXACERBATES COLONIC INFLAMMATION IN MULTIPLE EXPERIMENTAL MODELS OF INFLAMMATORY BOWEL DISEASE

Kimberly van der Sloot, MD/PhD candidate
University Medical Center Groningen
CIGARETTE SMOKE INCREASES RISK FOR COLORECTAL NEOPLASIA IN INFLAMMATORY BOWEL DISEASE

Kaitlin Whaley, MD
Cincinnati Children’s Hospital Medical Center
ANTI-TNF PHARMACOKINETICS AND RESPONSE TO THERAPY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS (THE ARCH STUDY)

Jilei Zhang, PhD
University of Illinois at Chicago
TRANSFER RNA QUEUOSINE MODIFICATION ENZYME MANIPULATES TIGHT JUNCTION PROTEINS IN INFLAMMATORY BOWEL DISEASE

Application Information

The Crohn’s & Colitis Congress will award complementary registration to the 2022 meeting to up to ten young investigators and five nurses and advanced practice providers. Applications will be accepted from 9 a.m. EDT on Wednesday, Sept. 8 through 9 p.m. EDT on Wednesday, Oct. 20, 2022. 

Applicants are:

  • Early career investigators currently in training or within five years of completing their training.
  • Listed as the presenting author of an abstract accepted for oral or poster presentation at the 2021 Crohn’s & Colitis Congress..

Recipients will receive complementary registration to the 2021 meeting.

The deadline for young investigators and nurses to submit an application for complementary registration to the 2022 meeting has passed. 

Notifications will be sent to all applicants in early December. 

Young Investigators Abstract Award

  • Congress administration will award up to ten young investigators complementary registration for the 2023 Congress.
  • Applicants for the award must be an early career investigator currently in training or within five years of completing their training; additionally, applicants must be listed as the presenting author of an abstract accepted for presentation at the 2023 Crohn’s & Colitis Congress.
  • To apply, complete and submit all three award questions as part of an abstract submission by 12 p.m. (noon) EDT on Friday, Oct. 21, 2022.
  • Applicants will be asked to briefly describe their career stage and how Congress attendance will benefit their career in 4000 or fewer characters.
  • Applicants are not required to be the submitting author of the abstract; instead, submitting authors may complete the application fields on behalf of the applicant provided that the applicant composes the personal statement.
  • Prior award recipients are not eligible to receive a 2023 award.
  • Award notifications will be emailed to applicants in December 2022.

Applicants for the Young Investigators Abstract Award must be:

  • Early career investigators currently in training or within five years of completing their training.
  • Listed as the presenting author of an abstract accepted for oral or poster presentation at the 2022 Crohn’s & Colitis Congress.

Applications may be submitted at the abstract submission site. To apply for the award, complete the “Awards” fields when submitting an abstract. Applicants are asked to verify their eligibility and also provide a brief (4000 characters maximum) personal statement.

Applicants are not required to be the submitting author of the abstract; instead, submitting authors may complete the application fields on behalf of the applicant provided that the applicant composes the personal statement.

Applications are due at the abstract submission site by 9 p.m. EDT on Wednesday, Oct. 20, 2021. Previous recipients of the award are not eligible to apply.

Contact Congress administration with any questions about applying.

Nurses/Advanced Practice Providers Award

  • The Crohn’s & Colitis Congress will award up to five nurses or advanced practice providers complimentary registration to the 2023 Crohn’s & Colitis Congress.
  • Applicants for the Nurses/Advanced Practice Providers Award must be a registered nurse, clinical nurse specialist, nurse practitioner, or physician assistant in any practice setting currently involved in IBD patient management. Graduate students in any of the listed fields with an identified interest in the IBD patient population will also be considered.
  • Applications for the Nurses/Advanced Practice Providers Award will be accepted online through 12 p.m. (noon) EDT on Friday, Oct. 21, 2022.
  • To apply for the award, applicants must submit the following materials:
    • Current curriculum vitae.
    • Estimate of the average number of IBD patients seen weekly in your practice setting.
    • A brief (500 words or fewer) statement as to why attending the Crohn’s & Colitis Congress is important to you and the patients you manage. Please state the significance your participation in this conference will have on your practice, patient care or knowledge of IBD. Include how you will share your experience with others (if applicable), list any questions you hope this conference will help answer, or share any ideas or projects that you hope to develop further as a result of attending this conference.
  • Previous recipients of the award are not eligible to receive a 2023 award.
  • Award notifications will be sent by email in December 2022.

Nurses and advanced practice providers may apply for complementary registration to the 2022 Crohn’s & Colitis Congress.

As part of the application, applicants are asked to submit their CV and a brief (500 words or less) personal statement.

Applications must be submitted by 9 p.m. EDT on Wednesday, Oct. 20, 2021. Previous recipients of the award are not eligible to apply.

Contact Congress administration with any questions about applying.

This website uses cookies to provide you with the best experience on our website. If you wish to disable cookies, please do so in your browser settings. Your continued use of our site without disabling your cookies is subject to the cookie policy. Learn More